Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TTY Biopharm Company Limited (4105) Income Statement

TTY Biopharm Company Limited Income Statement

Last quarter (Q2 2026), TTY Biopharm Company Limited's total revenue was NT$1.65B, an increase of 8.96% from the same quarter last year. In Q2, TTY Biopharm Company Limited's net income was NT$406.42M. See TTY Biopharm Company Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 6.45BNT$ 5.89BNT$ 5.51BNT$ 5.06BNT$ 4.54B
NT$ 3.72BNT$ 3.41BNT$ 3.22BNT$ 3.02BNT$ 2.77B
NT$ 1.96BNT$ 2.02BNT$ 1.85BNT$ 1.79BNT$ 1.61B
Depreciation and AmortizationNT$ 196.58MNT$ 202.35MNT$ 200.90MNT$ 186.28MNT$ 167.28M
NT$ 1.90BNT$ 1.73BNT$ 1.66BNT$ 1.50BNT$ 1.14B
NT$ 1.70BNT$ 1.39BNT$ 1.38BNT$ 1.23BNT$ 1.11B
NT$ 421.22MNT$ 491.90MNT$ 44.02MNT$ -134.94MNT$ -68.28M
NT$ 2.13BNT$ 1.89BNT$ 1.42BNT$ 1.29BNT$ 1.09B
NT$ 1.56BNT$ 1.45BNT$ 1.13BNT$ 1.09BNT$ 831.89M
Per Share Metrics
Basic EPSNT$ 6.27NT$ 5.83NT$ 4.54NT$ 4.40NT$ 3.35
Diluted EPSNT$ 6.27NT$ 5.82NT$ 4.53NT$ 4.40NT$ 3.34
Weighted Average Shares Outstanding263.91M248.65M248.65M248.65M248.65M
Weighted Average Shares Outstanding (Diluted)263.91M249.17M249.12M249.01M249.06M

Currency in TWD

TTY Biopharm Company Limited Earnings and Revenue History

02.5B5B7.5B17.5 %20 %22.5 %25 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin